A Transcriptomic-Based Tool to Predict Gemcitabine Sensitivity in Advanced Pancreatic Adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Nicolas,Fraunhoffer ^[1] ; Brice,Chanez ^[2] ; Carlos,Teyssedou ^[3] ; Pdac Chemo Sensitivity Prediction Working Group ^[4] ; Juan L,Iovanna ^[2] ; Emmanuel,Mitry ^[5] ; Nelson J,Dusetti

作者单位： Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France. ^[1] Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. ^[2] Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France; Endocrine and Visceral Surgery Department, University Hospital Angers, Angers, France; Haut Anjou Hospital Center, Château-Gontier, France. ^[3] Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: juan.iovanna@inserm.fr. ^[4] Cancer Research Center of Marseille (CRCM), INSERM, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France. Electronic address: nelson.dusetti@inserm.fr. ^[5]

主题词人类(Humans);胰腺肿瘤(Pancreatic Neoplasms);腺癌(Adenocarcinoma);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols)

DOI 10.1053/j.gastro.2022.11.035

PMID 36496056

发布时间 2023-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交